In HCC, miR-622 directly targets the 3′ untranslated region of CXC chemokine receptor 4 (CXCR4) and inhibits tumorigenesis via suppression of CXCR4 expression (30). The gene discussed is CXCR4; the disease is hepatocellular carcinoma.